LIALDA DR 1.2 GM TABLET
FDA nonproprietary name: mesalamine
For 30 tablets
Pharmacies pay
$268.40 filed
30 × $8.94652 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$313.66 estimated
$268.40 + $40.26 (15%) + $5.00 fee per fill = $313.66
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LIALDA DR 1.2 GM TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as mesalamine, under the trade name “Lialda”.
FDA gives its dosage form as tablet, delayed release and its route as oral.
The labeler, the company named on the label, is Takeda Pharmaceuticals America, Inc.
FDA’s Established Pharmacologic Class for it is Aminosalicylate.
The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $268.40 for 30 tablets (30 × $8.94652 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $0.7809 per EA filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · Why 30 tablets · NADAC explanation codes
All 3 NDCs
- 54092-0476-01 · Takeda Pharmaceuticals America, Inc. · $8.94652 per EA · eff. 2026-09-23 filed
- 54092-0476-02 · Takeda Pharmaceuticals America, Inc. · $8.94652 per EA · eff. 2026-09-23 filed
- 54092-0476-12 · Takeda Pharmaceuticals America, Inc. · $8.94652 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
10 other products in the NADAC file share the FDA nonproprietary name mesalamine with LIALDA DR 1.2 GM TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CANASA 1,000 MG SUPPOSITORY | $37.10967 per EA filed | $36.05608 per EA filed |
| LIALDA DR 1.2 GM TABLET this page | $8.94652 per EA filed | We don’t know yet |
| MESALAMINE 1,000 MG SUPP | $1.28382 per EA filed | We don’t know yet |
| MESALAMINE 4 GM/60 ML ENEMA | $0.09843 to $0.17585 per ML filed | We don’t know yet |
| MESALAMINE 4 GM/60 ML KIT | $134.90444 per EA filed | We don’t know yet |
| MESALAMINE 800 MG DR TABLET | $4.02045 per EA filed | $2.00989 per EA filed |
| MESALAMINE DR 1.2 GM TABLET | $0.7809 per EA filed | $2.00989 per EA filed |
| MESALAMINE DR 400 MG CAPSULE | $2.69898 per EA filed | $2.00989 per EA filed |
| MESALAMINE ER 0.375 GRAM CAP | $0.47798 per EA filed | $1.37992 per EA filed |
| PENTASA 250 MG CAPSULE | $2.90086 per EA filed | $5.03307 per EA filed |
| PENTASA 500 MG CAPSULE | $5.82619 per EA filed | $5.03307 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 3 NDCs’ NADAC prices is $8.94652 per EA filed.
Of the 12 other products in FDA’s Aminosalicylate class priced per EA, 2 have a higher middle NADAC price and 10 a lower one. The one in the middle is MESALAMINE 1,000 MG SUPP, at $1.28382 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: MESALAMINE DR 1.2 GM TABLET. Ask your pharmacist or prescriber; do not switch on your own.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.